Purchase this article with an account.
I.J. Immonen, J. Eerola, P.J. Tienari, T. Tervo, J. Moilanen, P. Ranta, P. Tommila, J. Holopainen; ApoE e3 Haplotype Modulating the Risk of Alzheimer's Disease Does Not Affect the Risk of Age–Related Macular Degeneration . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3201.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose: To evaluate, whether ApoE e3 haplotype, as defined by polymorphism at position –219 of the ApoE promoter, modulates the risk of age–related macular degeneration in subjects with the e3/e3 genotype. Methods:The e3 haplotype was analyzed in 70 e3/e3 individuals with age–related macular degeneration (AMD). Controls consisted of a population sample of 395 e3/e3 individuals from the same region, aged 65. Results:The frequency of chromosomes with the –219T haplotype was 0.436 in AMD patients and 0.411 in controls. The corresponding frequences for the –219G haplotype were 0.564 and 0.589. Conclusions:The e3 –219G haplotype, raported to be connected with an increase in the risk of Alzheimer's disease, compared to the –219T is neutral in relation to AMD.
This PDF is available to Subscribers Only